Navigation Links
BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles
Date:6/17/2009

Ex-police officer and certified search & rescue manager won contest to clone beloved pet Trakr, hero of 9-11 rescue efforts

LOS ANGELES, June 17 /PRNewswire/ -- Can you clone a hero? Retired police officer James Symington, owner of the late search and rescue dog and 9-11 hero, Trakr, will receive five answers to that question on Wednesday June 17, 2009. BioArts International, a Northern California biotech company that is offering the first commercial dog cloning service in the world, will be presenting Symington with five puppies - perfect clones of Trakr - at a press conference Wednesday afternoon in Los Angeles.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090617/SF33909)

Symington won the "Golden Clone Giveaway" contest sponsored by BioArts International in 2008, by writing to the company and explaining why Trakr was an ideal candidate for cloning. The company's other dog cloning clients have paid an average of $144,000 to clone their canine pets, but Symington will receive his puppy clones of Trakr for free.

BioArts International holds the sole, worldwide license for the cloning of dogs, cats and endangered species, and is partnered with Sooam Biotech Research Foundation of South Korea, the world's foremost experts in canine cloning. The cloning of Trakr occurred at Sooam under the direction of Dr. Hwang Woo-Suk, who produced the world's first canine clone in 2005.

"We received many very touching submissions to our contest, describing some truly amazing dogs," says Lou Hawthorne, CEO of Bio Arts International. "But Trakr's story blew us away. His many remarkable capabilities were proven beyond all doubt in our nation's darkest hour - and we're proud to have cloned him successfully."

Trakr was credited with hundreds of arrests and recovered more than $1
'/>"/>

SOURCE BioArts International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel
2. International Medical Device Maker; Four Executives Charged in Connection With Unlawful Clinical Trials
3. URAC and CARF International Announce New Survey Tool for Health Care Case Management Studies
4. Kevin Niksarli, M.D. of Manhattan Lasik Center Reviews Pros and Cons of Contact Lenses vs. iLASIK at an International Meeting on 7/1/2009
5. Hamner Institutes and UNC Launch International Drug Safety Institute
6. Genomas Presents Drug-Specific Genetic Determinants of Statin Safety and Efficacy at the XV International Symposium on Atherosclerosis
7. Boston Scientifics Urology/Gynecology Products Featured in Studies at International Urogynecological Association Annual Meeting
8. Travis McCoy, Lead Vocalist & Songwriter of Alternative Hip Hop Band Gym Class Heroes, Travels to South Africa, Philippines and India as MTV Internationals 2009 Staying Alive Foundation Ambassador
9. Brinker International Announces Support of Senates Agreement on Uniform Nutrition Disclosure
10. Catholic Charities Executive to Speak at Caritas Internationalis
11. Dr. Philip A. DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Strongly influenced by their self-interest, ... there are no consequences, researchers in Georgia State ... This could imply that humans are less concerned ... researchers said. Their findings are published in the ... of unfairness is affected by their self-interest, indicating ...
(Date:8/21/2014)... August 21, 2014 Local agencies in ... larger discounts for specific protection plans, according to released ... consumers to quote life insurance from local agencies using ... local agents that appear inside of the national system ... method of price reviews this year. Adults who enter ...
(Date:8/21/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW) , Browse 138 market ... and in-depth TOC on “Proteomics Market by Technology ...
(Date:8/21/2014)... Vegas, NV (PRWEB) August 21, 2014 ... the Association for Packaging and Processing Technologies. They ... It’s the view into a whole new world ... of engaged attendees, interactive education, and the latest ... lifecycle solutions from exhibitors. This year at Pack ...
(Date:8/21/2014)... 21, 2014 Today, Zane Benefits, the ... the premium tax credits in 2015. , According to ... part of the Affordable Care Act (ACA), premium tax ... individual health insurance through the Health Insurance Marketplaces. , ... and the amount of the tax credits, updated for ...
Breaking Medicine News(10 mins):Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2
... of U.S. patents, has expanded its free offerings, providing access ... host of other improvements, making it even easier to find and ... ... 9, 2008 -- PatentStorm , the searchable website of millions ...
... and lay the groundwork for Phase 2 trials ... Leukemia (AML) settings , , ... Pharmaceuticals today announced that a Phase 1 dose ... the recommended dose for Phase 2 studies and ...
... today that a total of,20 U.S. and global abstracts ... presentation at the 2008 San Antonio,Breast Cancer Symposium (SABCS) ... breast cancer to be presented on Sunday, December,14, by ... Two U.S. abstracts to be presented ...
... Dec. 9 Frost & Sullivan, a global ... recently held Manufacturing Summit, hosted the India Manufacturing ... Bangalore. Instituted in 2004, the awards aim to ... manufacturing capabilities and acknowledge the best facilities in ...
... an extended period of time when parents grappling with the natural grief ... 10 ways relatives and friends can make the holidays just a little ... Friends, the world,s largest self help support organization with more than 600 ... ...
... leading FDA software development company - provides medical device makers with ... technical report, available now. , ... (PRWEB) December 9, ... software development company Full Spectrum informs medical device ...
Cached Medicine News:Health News:PatentStorm Releases U.S. Patent Applications and Other Features 2Health News:Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting 2Health News:Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting 3Health News:Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting 4Health News:Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting 5Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 2Health News:Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium 3Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 2Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 3Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 4Health News:Excellence in Supply Chain and Manufacturing Recognized at Frost & Sullivan's India Manufacturing Excellence Awards 2008 5Health News:Ten Ways You Can Help a Family During the Holidays After a Child Dies 2Health News:Aimed at Medical Device Makers, FDA Software Development Company Full Spectrum Releases Free Technical Report on Software Protection Technology 2
(Date:8/21/2014)... Aug. 21, 2014 CVS Caremark Corporation (NYSE: ... Reference Yields and consideration payable in connection with its previously ... 7, 2014 for (1) any and all of its 6.250% ... (2) up to a maximum amount of its 6.125% Senior ... Senior Notes due 2017 (collectively, the "Maximum Tender Offer Notes" ...
(Date:8/21/2014)... HOUSTON , Aug. 21, 2014 ... innovation in paediatric medicine by awarding the three ... Paediatric Formulation initiative (EuPFI) conference . The ... 17 – 18 in Athens, Greece ... by pharmacy students and professionals, from which three ...
(Date:8/21/2014)... , Aug. 21, 2014   Royal Philips ... today announced it has received 510(k) clearance from ... its precision planning application for Transcatheter Aortic-Valve Implantation ... application provides interventionalists with pre-procedural, high-precision positioning to ... TAVI planning application is available as part of ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3
... MONICA, Calif., May 8, 2012 Reprints Desk, Inc., ... and first sale of its new mobile-web application ... iPads, mobile devices, product websites, and portals for ... Article Viewer for use by companies in Pharmaceuticals, Biotechnology, ...
... PHILADELPHIA, May 8, 2012  The new prescription sleep aid ... and only prescription sleep aid approved by the U.S. ... insomnia when a middle-of-the-night awakening is followed by difficulty ... four hours of bedtime remaining before the planned time ...
Cached Medicine Technology:Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 2Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 3Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV 2Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV 3Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV 4Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV 5Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV 6
... 2.0 is a reagent and probe system ... The high throughput plate based system is ... provides a unique approach for RNA detection ... using branched DNA (bDNA) technology. Branched DNA ...
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
...
Medicine Products: